Cargando…
Cancer treatments touch a wide range of values that count for patients and other stakeholders: What are the implications for decision‐making?
BACKGROUND: Cancer rates and expenditures are increasing, resulting in debates on the exact value of this care. Perspectives on what exactly constitutes worthwhile values differ. This study aims to explore all values–elements regarding new oncological treatments for patients with cancer and all stak...
Autores principales: | Vrinzen, Cilla E. J., Bloemendal, Haiko J., Stuart, Esra, Makady, Amr, van Agthoven, Michel, Koster, Mariska, Merkx, Matthias A. W., Hermens, Rosella P. M. G., Jeurissen, Patrick P. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028089/ https://www.ncbi.nlm.nih.gov/pubmed/36373590 http://dx.doi.org/10.1002/cam4.5336 |
Ejemplares similares
-
A Systematic Review and Multilevel Regression Analysis Reveals the Comorbidity Prevalence in Cancer
por: Vrinzen, Cilla E.J., et al.
Publicado: (2023) -
Making Intracellular Sensors Count
por: Merkx, Maarten
Publicado: (2018) -
The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: Insights from multiple stakeholders
por: Wasir, Riswandy, et al.
Publicado: (2019) -
TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases
por: Annemans, Lieven, et al.
Publicado: (2020) -
Making the Numbers Count
por: Maskell, Brian
Publicado: (2009)